Experiential Learning with Ketamine: A Mixed-Methods Exploratory Study on Prescription and Perception
Annette Ilg,Christine Beltran,Jenny Shih,Tuyen Yankama,Margaret Hayes,Ari Moskowitz
DOI: https://doi.org/10.2147/tcrm.s462760
2024-06-22
Therapeutics and Clinical Risk Management
Abstract:Annette M Ilg, 1 Christine P Beltran, 2 Jenny A Shih, 3, 4 Tuyen T Yankama, 5 Margaret M Hayes, 6, &ast Ari L Moskowitz 6, 7, &ast 1 Division of Emergency Critical Care, Department of Emergency Medicine, Mass General Brigham, Boston, MA, USA; 2 Carl J, Shapiro Institute for Education and Research, Beth Israel Deaconess Medical Center, Boston, MA, USA; 3 Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA; 4 Department of Pulmonary and Critical Care, Brigham and Women's Hospital, Boston, MA, USA; 5 Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, USA; 6 Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA; 7 Division of Critical Care Medicine, Department of Medicine, Montefiore Medical Center, Bronx, New York, NY, USA &astThese authors contributed equally to this work Correspondence: Annette M Ilg, Mass General Brigham, Department of Emergency Medicine, Division of Critical Care, 75 Francis St, Boston, MA, 02115, USA, Email Background: Incorporating unfamiliar therapies into practice requires effective longitudinal learning and the optimal way to achieve this is debated. Though not a novel therapy, ketamine in critical care has a paucity of data and variable acceptance, with limited research describing intensivist perceptions and utilization. The Coronavirus-19 pandemic presented a particular crisis where providers rapidly adapted analgosedation strategies to achieve prolonged, deep sedation due to a surge of severe acute respiratory distress syndrome (ARDS). Question: How does clinical experience with ketamine impact the perception and attitude of clinicians toward this therapy? Methods: We conducted a mixed-methods study using quantitative ketamine prescription data and qualitative focus group data. We analyzed prescription patterns of ketamine in a tertiary academic ICU during two different time points: pre-COVID-19 (March 1–June 30, 2019) and during the COVID-19 surge (March 1–June 30, 2020). Two focus groups (FG) of critical care attendings were held, and data were analyzed using the Framework Method for content analysis. Results: Four-hundred forty-six medical ICU patients were mechanically ventilated (195 pre-COVID-19 and 251 during COVID-19). The COVID-19 population was more likely to receive ketamine (81[32.3%] vs 4 [2.1%], p < 0.001). Thirteen respondents participated across two FG sessions (Pre-COVID = 8, Post-COVID=5). The most prevalent attitude among our respondents was discomfort, with three key themes identified as follows: 1) lack of evidence regarding ketamine, 2) lack of personal experience, and 3) desire for more education and protocols. Conclusion: Despite a substantial increase in ketamine prescription during COVID-19, intensivists continued to feel discomfort with utilization. Factors contributing to this discomfort include a lack of evidence, a lack of experience, and a desire for more education and protocols. Increase in experience with ketamine alone was not sufficient to minimize provider discomfort. These findings should inform future curricula and call for process improvement to optimize continuing education. Keywords: analgosedation, continuing education, learning theory, ketamine, critical care Ketamine is a potent sedative and anesthetic agent with a favorable hemodynamic profile. 1 Though not a novel therapy, the evidence base guiding ketamine use for analgosedation in the critically ill is sparse. While data is limited, studies have demonstrated that ketamine is compatible and safe to use, 2,3 and systematic reviews have demonstrated that ketamine may reduce analgesic consumption in the ICU. 4–6 Yet, the Society of Critical Care Medicine guidelines provide little to no mention of ketamine, 7 and substantial practice variability in the prescription of ketamine in the ICU exists. 8 In order to incorporate evolving and unfamiliar therapies into practice, effective longitudinal learning is critical. The optimal way to achieve this is debated by varying education theories. Halsted's See One, Do One, Teach One methodology, frequently used in medical education, argues that increased experience alone should be sufficient to achieve competency. 9,10 More recently, however, Kolb's Experiential learning theory suggests additional components such as abstract conceptualization and reflective observation are needed. 9–11 How providers adapt to novel therapies and respond during a crisis is v -Abstract Truncated-
health care sciences & services